Isbn: 9781607619796 - experimental and applied immunotherapy (13 risultati)

Condizione: New. In English.

Condizione: New. Experimental and Applied Immunotherapy offers a roadmap to the creation of immunotherapies, which have prominent cancer-fighting potential. Readers will find discussions of T cell and non-T cell therapy, monoclonal antibody therapy, dendritic cell-based cancer vaccines, and more. Editor(s): Medin, Jeffrey; Fowler, Daniel L.T. Num Pages: 442 pages, 24 black & white tables, biography. BIC Classification: MJCM; PSF. Category: (P) Professional & Vocational. Dimension: 250 x 164 x 32. Weight in Grams: 810. . 2010. Hardback. . . . . …

Condizione: New. pp. 462.

Hardcover. Condizione: Brand New. 1st edition. 442 pages. 9.25x6.25x1.25 inches. In Stock.

Condizione: New. Experimental and Applied Immunotherapy offers a roadmap to the creation of immunotherapies, which have prominent cancer-fighting potential. Readers will find discussions of T cell and non-T cell therapy, monoclonal antibody therapy, dendritic cell-based cancer vaccines, and more. Editor(s): Medin, Jeffrey; Fowler, Daniel L.T. Num Pages: 442 pages, 24 black & white tables, biography. BIC Classification: MJCM; PSF. Category: (P) Professional & Vocational. Dimension: 250 x 164 x 32. Weight in Grams: 810. . 2010. Hardback. . . . . Books ship from the US and Ireland. …

Hardcover. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Condizione: new. Questo è un articolo print on demand.

Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Reflects the inter-disciplinary nature of translational immunotherapy, and includes a description of the cellular players/molecular effectors and the distinct therapeutic strategies Ideal for laboratory researchers and post-baccalaureate level students Each.…

Buch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Immunotherapy is now recognized as an essential component of treatment for a widevariety of cancers. It is an interdisciplinary field that is critically dependent upon animproved understanding of a vast network of cross-regulatory cellular populations anda diversity of molecular effectors; it is a leading example of translational medicinewith a favorable concept-to-clinical-trial timeframe of just a few years. There are manyestablished immunotherapies already in existence, but there are exciting new cancer immunotherapies just on the horizon, which are likely to be more potent, less toxic and more cost effective than many therapies currently in use.Experimental and Applied Immunotherapy is a state-of-the-art text offering a roadmapleading to the creation of these future cancer-fighting immunotherapies. It includes essaysby leading researchers that cover a wide variety of topics including T cell and non-Tcell therapy, monoclonal antibody therapy, dendritic cell-based cancer vaccines, mesenchymalstromal cells, negative regulators in cancer immunology and immunotherapy,non-cellular aspects of cancer immunotherapy, the combining of cancer vaccines withconventional therapies, the combining of oncolytic viruses with cancer immunotherapy,transplantation, and more. The field of immunotherapy holds great promise that willsoon come to fruition if creative investigators can bridge seemingly disparate disciplines,such as T cell therapy, gene therapy, and transplantation therapy. This text is a vital tool in the building of that bridge. 460 pp. Englisch.…

Buch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Immunotherapy is now recognized as an essential component of treatment for a widevariety of cancers. It is an interdisciplinary field that is critically dependent upon animproved understanding of a vast network of cross-regulatory cellular populations anda diversity of molecular effectors; it is a leading example of translational medicinewith a favorable concept-to-clinical-trial timeframe of just a few years. There are manyestablished immunotherapies already in existence, but there are exciting new cancer immunotherapies just on the horizon, which are likely to be more potent, less toxic and more cost effective than many therapies currently in use.Experimental and Applied Immunotherapy is a state-of-the-art text offering a roadmapleading to the creation of these future cancer-fighting immunotherapies. It includes essaysby leading researchers that cover a wide variety of topics including T cell and non-Tcell therapy, monoclonal antibody therapy, dendritic cell-based cancer vaccines, mesenchymalstromal cells, negative regulators in cancer immunology and immunotherapynon-cellular aspects of cancer immunotherapy, the combining of cancer vaccines withconventional therapies, the combining of oncolytic viruses with cancer immunotherapytransplantation, and more. The field of immunotherapy holds great promise that willsoon come to fruition if creative investigators can bridge seemingly disparate disciplinessuch as T cell therapy, gene therapy, and transplantation therapy. This text is a vital tool in the building of that bridge.Springer-Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 460 pp. Englisch.…

Condizione: New. Print on Demand pp. 462 24 Illus. (Mostly Col.).

Condizione: New. PRINT ON DEMAND pp. 462.

Buch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Immunotherapy is now recognized as an essential component of treatment for a widevariety of cancers. It is an interdisciplinary field that is critically dependent upon animproved understanding of a vast network of cross-regulatory cellular populations anda diversity of molecular effectors; it is a leading example of translational medicinewith a favorable concept-to-clinical-trial timeframe of just a few years. There are manyestablished immunotherapies already in existence, but there are exciting new cancer immunotherapies just on the horizon, which are likely to be more potent, less toxic and more cost effective than many therapies currently in use.Experimental and Applied Immunotherapy is a state-of-the-art text offering a roadmapleading to the creation of these future cancer-fighting immunotherapies. It includes essaysby leading researchers that cover a wide variety of topics including T cell and non-Tcell therapy, monoclonal antibody therapy, dendritic cell-based cancer vaccines, mesenchymalstromal cells, negative regulators in cancer immunology and immunotherapynon-cellular aspects of cancer immunotherapy, the combining of cancer vaccines withconventional therapies, the combining of oncolytic viruses with cancer immunotherapytransplantation, and more. The field of immunotherapy holds great promise that willsoon come to fruition if creative investigators can bridge seemingly disparate disciplinessuch as T cell therapy, gene therapy, and transplantation therapy. This text is a vital tool in the building of that bridge.…